FOOD AND DRUG ADMINISTRATION

First Page		Document Content
Ribavirin Interferon Pegylated interferon PEGylation Hepatitis C Peginterferon alfa-2a Telaprevir Antivirals Pharmacology Medicine		FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 30,19 KB Share Document on Facebook

	ABSTRACT FINAL ID: LB-7 TITLE: Preliminary safety and efficacy of REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated interferon alpha 2a in treatment naïve Caucasian patients DocID: 1sU8R - View Document
	PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 , DocID: 1r5tc - View Document
	Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1, Aung Naing2, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5, DocID: 1qBPZ - View Document
	PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2, DocID: 1p7VM - View Document
	Microsoft Word - MVP Receives European Patent on Long-Acting MS DrugOld MSW.doc DocID: 1oICB - View Document